Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
Detection Principle
ImmunoAssay-Antibody
Testing Method Category
Other Immuno assay
Testing Method
A: Acro 2019-nCoV IgG/IgM Rapid Test (Acro Biotech Inc, USA); B:OnSite Covid-19 IgG/IgM Rapid Test (CTK Biotech, Inc, USA); C: COVID-19 IgG/IgM Rapid Test Kit (WuHanUNscience Biotechnology Co., China); D: Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2 (Jiangsu Medomics medical technology Co., China); E: Wantai SARS-CoV-2 Ab Rapid Test Kit (Beijing Wantai Biological Pharmacy Enterprise Co, China); F: Novel coronavirus 2019-nCov) IgM/IgG Antibody Combo Test Kit (Hangzhoue Laihe Biotech Co, China); G: Novel Coronavirus (SARS-CoV-2) IgM Antibody Detection (Ki RayBiotech, USA); H: Novel Coronavirus (SARS-CoV-2) IgG Antibody Detection Kit (RayBiotech, USA); I: Lumiratek COVID-19 IgG/IgM Hurtigtest kassett (Hangzhou Biotest Biotech Co., China); J: Covid-19 IgG/IgM Rapid Test Cassette (SureScreen Diagnostics, UK); K: SARS-CoV-2 IgG/IgM Rapid Test (Zhuhai Encode Medical Engineering Co., China).
Testing Method - Additional Info
evaluation of performances of 11 rapid tests
Reported Performance
Remarks: all tests recovered IgM and IgG from hospitalized patients with varying sensitivity; in no-hospitalized participnts who had recovered from PCR-confirmed Covid-19, tests A, B, C, and D had higher IgG positivity rates than tests E, F, H I, and J; more detailed data available in tables.
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements
